Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

Acute Myeloid Leukemia Clinical Trial

Official title: Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

Status Completed

Clinical Trial Summary

Despite the suggestions that GA and frailty indices could be used to guide therapy selection, the ability to effectively incorporate the use of GA in older patients diagnosed with AML in a real-world clinic environment has not yet been established. Thus, in this study, the investigators seek to describe the feasibility of using this shorter GA tool, the mGA, administered via patient self-report on a touchscreen computer, as well as the real-time use and utility by clinicians and the correlation of mGA results on treatment decision-making.

Clinical Trial Description

This outcomes study has a two-part intervention that includes 1) provider education and 2) patient and provider use of Carevive Treatment Care Planning technology. The provider education component of the intervention highlights evidenced guidelines and investigational agents in the treatment of AML in older adults. The Carevive CPS will be used for the second component of the intervention. The results of this study will provide important information about drivers of treatment decision-making and practice patterns, feasibility of a technology platform to incorporate important, but under-utilized components of value-based care into practice, and healthcare utilization data. ;

Related Conditions & MeSH terms

• Acute Myeloid Leukemia
• Leukemia
• Leukemia, Myeloid
• Leukemia, Myeloid, Acute

• NCT number: NCT04158726
• Study type: Interventional
• Source: Carevive Systems, Inc.
• Status: Completed
• Phase: N/A
• Start date: April 26, 2019
• Completion date: December 31, 2020